Literature DB >> 20487946

Effect of noradrenaline and vanadate on sodium, potassium-activated ATPase of human brain cortical homogenate.

P Serfözö1, E Sylvester Vizi.   

Abstract

Human brain cortical homogenate derived from surgical operations exhibited Na(+), K(+)-ATPase and K-p-nitrophenylphosphatase activity values of 2.12 +/- 0.08 ?mol P(i)/mg protein/15 min and 0.38 +/- 0.01 ?mol p-nitrophenol/mg protein/15 min, respectively which is in the range of those observed in rat brain cortical homogenates. Vanadate concentration dependently inhibited the activity of both enzymes. Noradrenaline, dopamine and isoprenaline reversed the inhibitory effect of vanadate in the presence of EDTA (0.2 mM). When Mg(2+) concentration was enhanced from 4 to 24 mM, the inhibitory effect of vanadate (1 ?M) was significantly potentiated. Evidence has been obtained that the effect of catecholamines is not a receptor mediated process; antagnoists such as phentolamine, phenoxybenzamine, propranolol, haloperidol failed to prevent the effect of adrenoceptor agonists. It is concluded that there is an interaction between vanadate and noradrenaline on human brain Na, K-ATPase.

Entities:  

Year:  1983        PMID: 20487946     DOI: 10.1016/0197-0186(83)90120-1

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  3 in total

1.  Vanadate inhibition of rat cerebral cortex Na+,K+-ATPase during postnatal development.

Authors:  J Folbergrová; P Mares
Journal:  Neurochem Res       Date:  1987-06       Impact factor: 3.996

2.  An endogenous factor which interacts with synaptosomal membrane Na+, K(+)-ATPase activation by K+.

Authors:  G Rodríguez de Lores Arnaiz
Journal:  Neurochem Res       Date:  1993-06       Impact factor: 3.996

3.  The inhibitory activity of a brain extract on synaptosomal Na+, K+-ATPase is sensitive to carboxypeptidase A and to chelating agents.

Authors:  M Antonelli de Gómez de Lima; G Rodríquez de Lores Arnaiz
Journal:  Neurochem Res       Date:  1988-03       Impact factor: 3.996

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.